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Highlights for review 
 Dysregulated social perception is a possible causative factor for interpersonal difficulties in 
BN 
 Oxytocin inhibits the amygdala response to threat and modulates emotional reactivity 
 BN shows a similar increase in attentional processes to anger as the healthy comparison group  
 Intranasal oxytocin reduced the attentional bias to anger in both BN and the healthy 
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comparison group 
 
Abstract 
 
Background: Bulimia nervosa (BN) is characterized by binge eating and emotional dysregulation 
including increased negative affectivity (anger, anxiety). The aim of this study was to examine the 
effect of oxytocin on attentional processes towards anger in patients with BN. 
Method: The study design consisted of a double-blind, placebo-controlled within-subject crossover, 
single dose experiment. Sixty-four women (31 patients with BN and 33 healthy comparisons) 
completed self-reported measures to evaluate emotional difficulties and were administered a single 
dose of intranasal oxytocin (40IU) or placebo followed by a visual probe detection task to examine 
attentional orienting to angry or happy faces.  
Results: Patients with BN reported higher emotional dysregulation and more difficulties in controlling 
anger compared to the healthy comparison group. Patients with BN and the healthy women exhibited 
similar attentional bias to angry faces in the placebo condition. Intranasal oxytocin reduced the 
attentional bias towards angry faces in both the BN patients and the healthy women. 
Conclusions: We found that a single dose of oxytocin reduced vigilance towards angry faces in 
patients with BN as well as healthy women. The results showed that patients with BN are not different 
from healthy women in terms of vigilance towards threat.  
 
Keyword: oxytocin, bulimia nervosa, anger, emotional regulation, attentional bias 
 
 
 
 
 
1. Introduction  
A recent maintenance model of bulimia nervosa (BN) has proposed that elevated impulsivity, 
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sensitivity to punishment, and interpersonal difficulties reduce the rewarding aspects of social 
interaction (Treasure et al., 2018). This in turn is believed to feed into increased emotion dysregulation, 
shame, and information processing biases, leading to greater reliance on eating as a coping mechanism 
and source of reward. The model is supported by findings that people with BN show increased 
attention and sensitivity towards negative social cues (Caglar-Nazali et al., 2014; Cardi et al., 2014; 
Cardi et al., 2013). Observational studies have also reported that binge eating episodes are frequently 
preceded by negative affect, especially anger and interpersonal distress (Haedt-Matt and Keel, 2011). 
Moreover, experimental studies have found that people with BN are characterized by a high propensity 
to express anger inadequately (Krug et al., 2008), which can lead to binge eating through impulsive 
emotional dysregulation (Amianto et al., 2012). Furthermore the trajectory of improvement in 
emotional regulation associated with treatment varies between eating disorders with the most change 
found in BN (Mallorqui-Bague et al., 2018). 
Oxytocin, a neuropeptide, has a central role in neural circuits involved in social behaviour, 
appetite, anxiety, and stress. Previous work has suggested that oxytocin plays an important role in 
regulating social cognition by altering amygdala and prefrontal reactivity to social cues (Guastella and 
MacLeod, 2012; Ross and Young, 2009). Improvements in emotion recognition and theory of mind, 
and increased attention towards positive social cues following intranasal oxytocin among healthy 
people (Bakermans-Kranenburg and van, 2013; Domes et al., 2013; Macdonald and Macdonald, 2010). 
Oxytocin might contribute to the etiology of eating disorders, and social cognition is one of these 
pathways (Giel et al., 2018). Our pilot study found intranasal oxytocin similarly improved emotion 
recognition sensitivity in BN and healthy people (Kim et al., 2015), which suggested that reactivity to 
emotional stimuli may be a greater source of difficulties in BN and therefore, examining the effects of 
oxytocin in this area would be of interest. 
The aim of the study was to build on existing literature and examine the impact of a single 
dose of intranasal oxytocin on attentional bias towards emotional cues in BN. As anger in particular is 
believed to play an important role in the maintenance of disordered eating in BN, we were interested 
in examining the impact of intranasal oxytocin on attentional reactivity to angry in addition to happy 
and neutral faces. Our first hypothesis was that patients with BN would show increased attention to 
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angry faces due to sensitivity towards negative social cues. Our second hypothesis was that oxytocin 
would reduce attentional bias towards anger and increase the bias towards positive and neutral faces in 
BN. 
  
2. Materials and methods 
2.1. Participants  
Sixty-four young women [31 patients with BN and 33 healthy comparisons (HC)] took part in 
this study. Patients with BN were recruited from the outpatient clinic of Eating Disorders Clinic at 
Seoul Paik Hospital, Seoul, South Korea. The BN diagnosis was confirmed using a Structured Clinical 
Interview (First et al., 2007) based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5). The exclusion criteria for patients were as follows: active substance use disorder 
and psychotic disorder. Those who had other comorbidities were allowed. In the sample, the common 
psychiatric comorbid disorders were depressive disorders (n=13), anxiety disorders (n=8) and 
borderline personality disorder (n=7) based on DSM-5. Other than the 7 patients who were taking 
fluoxetine, patients who were taking psychiatric medications were excluded. 
The HC participants were students from the women’s university in Seoul, South Korea. The 
inclusion criteria were healthy females without a history of medical or psychiatric illnesses, not taking 
regular medication including the contraceptive pill, and a minimum age of 17 years. The exclusion 
criteria were as follows: self-reported history of psychiatric, developmental, or neurological disorders, 
and substance dependence.  
The sample size was based on an a priori power analysis conducted with G*Power (Faul et al., 
2007), which indicated a minimum sample size of 60 (power = 0.8) to detect significant effects. All 
participants provided written informed consent prior to participating in the study. The study protocol 
was approved by both the Korean Food and Drug Association Institutional Review Board (approval 
number: 12061) and the Institutional Review Board of Seoul Paik Hospital (approval number: IIT-
2012-096). This study was registered with the Clinical Research Information Service 
(http://cris.nih.go.kr) (registration number: KCT0000716). 
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2.2. Experimental design  
We applied a double-blind, placebo-controlled, within subjects, crossover design. The 
preparation methods for the oxytocin and placebo are shown in Supplementary Information 1. 
Participants without amenorrhea (n = 61) were tested during the follicular phase of their menstrual 
cycle (approximately days 3 through 12). All participants received a single dose of both oxytocin (40 
IU per dose) and placebo in separate sessions in accordance with current guidelines (Carson et al., 
2013). Each participant visited the laboratory twice for testing: once for the placebo condition and 
once for the oxytocin condition. The order of the placebo or oxytocin administration for each 
participant was determined randomly by a project coordinator who was not involved in the 
experiment. The visual probe detection task commenced 45 minutes after the intranasal administration 
of oxytocin or placebo. For further details please see Supplementary Information 2.  
 
2.3. Measurements 
2.3.1. Self-reported psychometric assessments 
All participants completed self-reported measures to evaluate emotional difficulties and 
eating disorders psychopathology. For further details please see Supplementary Information 3. 
 
2.3.2. Visual probe detection task 
A visual probe detection task was used to measure attentional biases. The stimuli consisted 
of happy (n = 15), angry (n = 15), and neutral (n = 15) facial expressions of 15 adults were selected 
from 2 databases of Korean facial expressions of emotion (Lee et al., 2013; Park et al., 2011). An 
emotional and a neutral face were presented simultaneously, side by side on a screen followed by a 
probe either at the target’s location (emotional face) or at the distractor’s location (neutral face). A 
fixation cross was displayed at the centre of the screen for 750 ms followed by the target and non-
target stimuli pair for 1,000 ms. The reaction time (RT) was measured from the onset of the visual 
probe following the prime until the button press. For further details please see Supplementary 
Information 4. 
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2.4. Statistical analysis 
We followed a standard analytical procedure for the visual probe detection task (Bradley et 
al., 1999). Only RTs from trials in which probes were correctly identified were included in the 
analysis. The correct response rates were 99.9% for the BN group and 99.7% for the HC group. Mean 
RTs were calculated for each participant, and the outlier trials were removed by excluding detection 
latencies beyond two standard deviations from their mean (i.e., from each individual’s mean RTs 
across all stimuli).  
Attentional bias (AB) was calculated for each matched trial type (happy-neutral, angry-
neutral) by subtracting the mean RT for probes replacing the emotional prime from the mean RT for 
probes replacing the neutral prime. A positive AB indicated increased attention for the emotional 
prime while a negative AB indicated attention away from the emotional prime. The AB data were 
analyzed by a 2x2x2 mixed linear model using SPSS 23 (SPSS Inc., Chicago, IL, USA). The drugs 
(oxytocin and placebo), emotions (happy and angry), and groups (BN and HC) were entered as fixed 
effects while the subjects were the random effect. Multiple models were built to evaluate the model fit 
based on variance-covariance structures. Based on the results from the 2 Log Likelihood, the Akaike 
Information Criterion, and the Schwarz Bayesian Criterion, final models with a diagonal structure 
were reported (Littell et al., 2000). The significant interactions were post hoc tested with simple 
effects tests, and the effect sizes for independent and dependent t-tests are reported using Cohen’s d. 
Statistical significance was set at p < 0.05.  
 
3. Results 
3.1. Demographic and clinical characteristics 
Demographic and clinical characteristics of the participants are summarized in Table 1. 
Ages, body mass indexes (BMI, kg/m2), and IQ levels were not significantly different among the 
patients with BN and the HC participants.  
 
(Table 1. Clinical characteristics of patients with bulimia nervosa and the healthy comparisons) 
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3.2. Attentional bias to anger/happy expression faces  
The AB scores among the BN and HC groups following oxytocin and placebo administration 
are presented in Table 2. The mixed model revealed no effects from the Drug x Emotion x Group 
interaction [F(1,228.082) = 0.002, p = 0.965] or Emotion [F(1,228.082) = 0.136, p = 0.712] on the AB 
scores. However, there were effects from the Drug x Emotion interactions [F(1,228.082) = 6.413, p = 
0.012] and Drug [F(1,228.082) = 6.118, p = 0.014] on the AB scores. Oxytocin significantly reduced 
the AB towards angry faces in both the patients with BN and HC participants. A simple effect test 
showed that the AB to angry faces was reduced by oxytocin [F(1,120.632) = 10.217, p = 0.002] 
whereas the AB to happy faces was not [F(1,118.034) = 0.002, p = 0.962]. Figure S1 for AB scores is 
presented in Supplementary Information 5. In addition, we explored whether oxytocin induced 
changes in the AB scores correlated with psychometric variables or not. The results are shown in 
Supplementary Information 6 and 7, and further investigation was not carried out as there were no 
differences in AB between the BN and HC groups.  
 
(Table 2. Attentional bias scores (in ms) towards angry and happy faces in the visual probe task for 
the oxytocin or placebo sessions in patients with bulimia nervosa and the healthy comparisons) 
 
4. Discussion 
The aim of this study was to examine the effect of intranasal oxytocin on the attentional 
reactivity to anger in patients with BN. The findings revealed that relative to the HC group, the BN 
participants did not show greater AB towards anger in the placebo condition. Instead, both groups 
showed similar vigilance towards the angry faces, which was attenuated by intranasal oxytocin.  
The present findings are supported by previous findings reporting positive impact of intranasal 
oxytocin on social cognition and cooperation among healthy individuals (Bakermans-Kranenburg and 
van, 2013; Domes et al., 2013; Macdonald and Macdonald, 2010). Moreover, findings from our 
previous work also showed that oxytocin similarly improved sensitivity to recognize basic emotions 
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among the BN and HC participants (Kim et al., 2015). Therefore, taken together these findings suggest 
that intranasal oxytocin may have a generally positive impact on social-emotional processing. 
In the context of the maintenance model of BN (Treasure et al., 2018), the present findings are 
encouraging that intranasal oxytocin could help to reduce elevated sensitivity to negative social cues, 
which in turn could help to alleviate information processing biases. Thus, ultimately intranasal 
oxytocin could potentially help to break the loop in BN. However, it is of importance to note that the 
present study did not find a group difference in AB towards anger or on the effects of oxytocin on AB. 
Thus, research with larger sample size may be needed to explore this possibility further.  
In this study, taking fluoxetine was accepted as an inclusion criterion. Although, it is a 
common clinical practice for treating BN, it might be confounding the effect of oxytocin on AB as 
SSRIs may modify specific neural dysfunctions correlated to negative cognitive biases (Di Simplicio 
et al., 2012). Therefore, the effect of fluoxetine on oxytocin and AB needs to be investigated in a 
further study. 
The main limitation of the present study was the relatively small sample size, which 
prevented further exploration of the potential confounding effects of individual differences, including 
childhood trauma and comorbid diagnoses. Additionally, a recent meta-analysis reported that the 
visual probe task may not be optimal for measuring AB and recommended that future studies should 
opt for more sensitive measures to examine the effects of oxytocin in AB (Leppanen et al., 2018). 
Third, the comorbid psychiatric disorders might influence the effect of oxytocin and AB. Finally, as 
the study was carried with a Korean sample, the study needs to be replicated for other racial ethnic 
populations to determine the generalizability of the findings. 
In conclusion, patients with BN show similar increased attention to threat stimuli, and similar 
moderation effects with oxytocin as found in healthy comparison group. 
 
Role of funding sources  
This research was supported by Basic Science Research Program through the National 
Research Foundation of Korea (NRF) funded by the Ministry of Education 
(2016R1D1A1A09917877). They had no role in the design, data collection, analysis, interpretation, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Kim et al., 9 
 
or writing of this report. The corresponding author has full access to all of the data in this study and 
has final responsibility for the decision to submit for publication. 
 
Author contributions 
YK and JT were involved with the study design. YK conducted the data collection and JE 
conducted the data analysis. YK, JT, JL, and ML were involved with the interpretation of results and 
the preparation of the draft article. All authors read and gave their approval of the final version of the 
article. 
 
Conflicts of interests 
There are no conflicts of interest for all authors. 
 
Acknowledgements 
We thank Ji Won Kang for her help collecting the data and Yo-Han Jeon for his help for the 
oxytocin analysis.
References 
Amianto, F., Siccardi, S., Abbate-Daga, G., Marech, L., Barosio, M., Fassino, S., 2012. Does anger 
mediate between personality and eating symptoms in bulimia nervosa? Psychiatry Research 200, 
502-512. 
Bakermans-Kranenburg, M.J., van Ijzendoorn, M.H., 2013. Sniffing around oxytocin: review and 
meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. 
Translational Psychiatry 3, e258. 
Bradley, B.P., Mogg, K., White, J., Groom, C., de Bono, J., 1999. Attentional bias for emotional faces 
in generalized anxiety disorder. British Journal of Clinical Psychology 38 (Pt 3), 267-278. 
Caglar-Nazali, H.P., Corfield, F., Cardi, V., Ambwani, S., Leppanen, J., Olabintan, O., Deriziotis, S., 
Hadjimichalis, A., Scognamiglio, P., Eshkevari, E., Micali, N., Treasure, J., 2014. A systematic 
review and meta-analysis of 'Systems for Social Processes' in eating disorders. Neuroscience and 
Biobehavioral Reviews 42, 55-92. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Kim et al., 10 
 
Cardi, V., Corfield, F., Leppanen, J., Rhind, C., Deriziotis, S., Hadjimichalis, A., Hibbs, R., Micali, 
N., Treasure, J., 2014. Emotional Processing of Infants Displays in Eating Disorders. PLoS One 
9. 
Cardi, V., Di Matteo, R., Corfield, F., Treasure, J., 2013. Social reward and rejection sensitivity in 
eating disorders: An investigation of attentional bias and early experiences. World Journal of 
Biological Psychiatry 14, 622-633. 
Carson, D.S., Guastella, A.J., Taylor, E.R., McGregor, I.S., 2013. A brief history of oxytocin and its 
role in modulating psychostimulant effects. Journal of Psychopharmacology 27, 231-247. 
Di Simplicio, M., Norbury, R., Harmer, C.J., 2012. Short-term antidepressant administration reduces 
negative self-referential processing in the medial prefrontal cortex in subjects at risk for 
depression. Molecular Psychiatry 17, 503-510. 
Domes, G., Sibold, M., Schulze, L., Lischke, A., Herpertz, S.C., Heinrichs, M., 2013. Intranasal 
oxytocin increases covert attention to positive social cues. Psychological Medicine 43, 1747-
1753. 
Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., 2007. G*Power 3: A flexible statistical power 
analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 
39, 175-191. 
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2007. Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P). Biometrics Research Department, New 
York State Psychiatric Institute, New York. 
Giel, K., Zipfel, S., Hallschmid, M., 2018. Oxytocin and Eating Disorders: A Narrative Review on 
Emerging Findings and Perspectives. Current Neuropharmacology 16, 1-10. 
Guastella, A.J., MacLeod, C., 2012. A critical review of the influence of oxytocin nasal spray on 
social cognition in humans: Evidence and future directions (vol 61, pg 410, 2012). Hormones and 
Behavior 61, 410-418. 
Haedt-Matt, A.A., Keel, P.K., 2011. Revisiting the affect regulation model of binge eating: a meta-
analysis of studies using ecological momentary assessment. Psychological Bulletin 137, 660-681. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Kim et al., 11 
 
Kim, Y.R., Eom, J.S., Yang, J.W., Kang, J., Treasure, J., 2015. The Impact of Oxytocin on Food 
Intake and Emotion Recognition in Patients with Eating Disorders: A Double Blind Single Dose 
Within-Subject Cross-Over Design. PLoS One 10. 
Krug, I., Bulik, C.M., Vall-Llovera, O.N., Granero, R., Aguera, Z., Villarejo, C., Jimenez-Murcia, S., 
Fernandez-Aranda, F., 2008. Anger expression in eating disorders: Clinical, psychopathological 
and personality correlates. Psychiatry Research 161, 195-205. 
Lee, K.U., Kim, J., Yeon, B., Kim, S.H., Chae, J.H., 2013. Development and Standardization of 
Extended ChaeLee Korean Facial Expressions of Emotions. Psychiatry Investigation 10, 155-163. 
Leppanen, J., Ng, K.W., Kim, Y.R., Tchanturia, K., Treasure, J., 2018. Meta-analytic review of the 
effects of a single dose of intranasal oxytocin on threat processing in humans. Journal of 
Affective Disorders 225, 167-179. 
Littell, R.C., Pendergast, J., Natarajan, R., 2000. Modelling covariance strucutre in the analysis of 
repeated measures data. Statistics in Medicine 19, 1793-1819. 
Macdonald, K., Macdonald, T.M., 2010. The peptide that binds: a systematic review of oxytocin and 
its prosocial effects in humans. Harvard Review of Psychiatry 18, 1-21. 
Mallorqui-Bague, N., Vintro-Alcaraz, C., Sanchez, I., Riesco, N., Aguera, Z., Granero, R., Jimenez-
Murcia, S., Menchon, J.M., Treasure, J., Fernandez-Aranda, F., 2018. Emotion Regulation as a 
Transdiagnostic Feature Among Eating Disorders: Cross-sectional and Longitudinal Approach. 
European Eating Disorders Review 26, 53-61. 
Park, J.Y., Oh, J.M., Kim, S.Y., Lee, M.K., Lee, C.R., Kim, B.R., Lee, E., An, S.K., 2011. Korean 
Facial Expressions of Emotion (KOFEE). Section of Affect & Neuroscience, Institute of 
Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, South Korea. 
Ross, H.E., Young, L.J., 2009. Oxytocin and the neural mechanisms regulating social cognition and 
affiliative behavior. Frontiers in Neuroendocrinology 30, 534-547. 
Treasure, J., Leslie, M., Chami, R., Fernández-Aranda, F., 2018. Are trans diagnostic models of eating 
disorders fit for purpose? A consideration of the evidence for food addiction. European Eating 
Disorders Review. 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Kim et al., 12 
 
 
Figures 
 
 
Table 1. Clinical characteristics of patients with bulimia nervosa and the healthy comparisons 
Characteristics BN (N=31) HC (N=33) t p d 
Age, years 23.87(3.99) 22.45(2.22) 1.76 0.082 0.42 
Age of onset, years 19.90(4.72) NA NA NA NA 
BMI, kg/m2 20.79(2.62) 20.85(2.40) -0.08 0.932 0.02 
Intelligence 106.44(13.79) 111.20(6.28) -1.69 0.096 0.44 
EDE-Q      
 Restraint 2.1(1.76) 0.87(0.86) 3.53 0.001 0.89 
 Eating Concern 2.77(1.67) 0.60(0.77) 6.56 <0.001 1.68 
 Shape Concern 3.50(1.58) 1.68(1.11) 5.25 <0.001 1.34 
 Weight Concern 4.04(1.46) 2.44(1.20) 4.72 <0.001 1.20 
 Global 3.11(1.36) 1.40(0.85) 5.93 <0.001 1.51 
BDI 18.52(12.23) 7.58(7.00) 4.31 <0.001 1.09 
STAI      
 State 53.65(13.16) 43.03(11.52) 3.37 0.001 0.85 
 Trait 57.81(12.32) 44.03(11.32) 4.58 <0.001 1.16 
STAXI       
Anger_State 13.55(7.97) 11.79(4.99) 1.06 0.290 0.26 
Anger_Trait 22.06(7.26) 18.73(6.13) 1.99 0.051 0.49 
Anger_Supression 19.81(4.85) 17.79(4.27) 1.77 0.082 0.44 
Anger_Expression 17.32(4.43) 15.03(3.95) 2.18 0.032 0.54 
Anger_Control 19.35(5.35) 19.24(4.92) 0.08 0.930 0.02 
DERS      
Non-acceptance 16.42(6.18) 9.82(5.64) 4.46 <0.001 1.11 
Goals 17.03(3.71) 13.90(2.91) 3.69 <0.001 0.93 
Impulsivity 15.74(5.20) 11.85(5.07) 3.03 0.004 0.75 
Awareness 17.65(4.90) 19.68(3.92) -1.80 0.076 0.45 
Strategies 21.68(6.34) 15.16(5.69) 4.25 <0.001 1.08 
Clarity 12.65(2.60) 12.97(1.74) -0.57 0.568 0.14 
Data are shown as mean (SD). d = Cohen’s d, BN = bulimia nervosa, HC = healthy comparison, BMI = body mass 
index, EDE-Q = Eating Disorders Examination Questionnaire, BDI = Beck Depression Inventory; STAI-State, 
Spielberger State and Trait Anxiety Inventory State Score, STAI-Trait = Spielberger State and Trait Anxiety Inventory 
Trait score, STAXI = State and the Trait Anger Expression Inventory, DERS = Difficulties in Emotion Regulation Scale, 
Non-acceptance = non-acceptance of emotional responses, Goal = difficulties engaging in goal-directed behaviour, 
Impulsivity = impulse control difficulties, Awareness = lack of emotional awareness, Strategies = limited access to 
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emotion regulation strategies, Clarity = lack of emotional clarity, NA = Not applicable 
Table 2. Attentional bias scores (in ms) towards angry and happy faces in the visual probe detection task for the 
oxytocin or placebo sessions in patients with bulimia nervosa and the healthy comparisons 
Prime face 
BN (n=31) 
t(df=30) p d 
HC (n=33) 
t(df=32) p d 
Placebo Oxytocin Placebo Oxytocin 
Happy 10.68(79.96) 9.72(74.34) 0.04 0.967 0.01 11.55(71.99) 13.72(58.35) -0.14 0.889 -0.03 
Angry 40.44(95.34) -12.10(90.34) 2.67 0.012 0.47 39.76(101.35) -9.51(74.97) 2.17 0.037 0.37 
Data are shown as mean (SD). Analyzed by paired t-test. BN = bulimia nervosa, HC = healthy comparison, d = Cohen’s d. 
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